Ocular iontophoretic device and method for inhibiting vascular endothelial growth factor (VEGF) using the same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6579276
APP PUB NO 20020099358A1
SERIAL NO

09767032

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An ocular iontophoretic device for delivering an aptamer to an affected area of a living being's eye for inhibiting VEGF function therein, the device comprising an active electrode assembly associated with a matrix and/or reservoir, wherein the matrix and/or reservoir includes an aptamer capable of inhibiting VEGF function. A method for treating an affected area of a living being's eye, comprising the steps of: associating an aptamer with an ocular iontophoretic device; positioning at least a portion of an ocular iontophoretic device on the eye of the living being; and iontophoretically delivering the aptamer to an affected area of the living being's eye.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ENCORE MEDICAL ASSET CORPORATION;IOMED, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lloyd, Lindsay B Salt Lake City, UT 13 410
Parkinson, Thomas M White Salmon, WA 8 89
Szlek, Malgorzata Salt Lake City, UT 7 46

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation